Full Text View
Tabular View
No Study Results Posted
Related Studies
Immune-Cell Membrane Trafficking
This study is currently recruiting participants.
Study NCT00638521   Information provided by University of Washington
First Received: March 12, 2008   Last Updated: December 31, 2008   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

March 12, 2008
December 31, 2008
June 2008
Assessment of protein and lipid changes in immune cells following severe injury [ Time Frame: 5/08 to 8/12 ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00638521 on ClinicalTrials.gov Archive Site
Assessment of severe injury effect on plasma and cellular lipid content [ Time Frame: 5/08 to 8/12 ] [ Designated as safety issue: No ]
Same as current
 
Immune-Cell Membrane Trafficking
Trauma and Sepsis Induced Changes in Immune-Cell Membrane Receptor Trafficking

Organ failure following trauma is a leading cause of morbidity and mortality. It appears that the development of organ failure is a direct result of an altered immune response. This altered response results in the production of circulating factors in the blood that causes direct injury to the injured patients' organs. The mechanism in which this altered immune response occurs is unknown. Based on work we have performed in our laboratory, we believe that this response is initiated on the cell membrane of particular immune cells known as macrophages. Although the cell membrane may appear uniform, it is not. The membrane is composed of specific segments that allow proteins to associate with each other forming receptors that are required for immune cell activation. These specific membrane components are composed of various lipids and cholesterol, and have been termed lipid rafts. Based on our laboratory work it appears that these lipid rafts can be altered following injury. In particular both the lipid and protein content within these raft segments may be altered allowing immune cells to become active leading to the production of factors that directly injure normal cells and organs. Thus, we plan to examine if these laboratory findings can be seen in patients suffering from trauma who develop clinical organ failure at Harborview Medical Center. If this is accomplished, this data will lead to the development of both prognostic and therapeutic interventions for the optimal care of injured patient

 
 
Observational
Cohort, Prospective
Severe Trauma
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
250
August 2012
 

Inclusion Criteria:

  • age 18 years or older, blunt or penetrating trauma and
  • one or more of the following: systolic blood pressure less than 90 mmHg at the scene or within one hour of arrival to the Emergency Department, 2) base deficit ≥ -6 within one hour of admission, 3) ISS greater than 25, or 4) more than 6 units of blood transfused in the first 12 hours.-

Exclusion Criteria:

Both
18 Years and older
Yes
 
United States
 
 
NCT00638521
Joseph Cuschieri, MD: Associate Professor, Department of Surgery, University of Washington
GM078054-01
University of Washington
National Institute of General Medical Sciences (NIGMS)
Principal Investigator: Joseph Cuschieri, MD University of Washington
University of Washington
December 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.